The efficacy and safety of zolpidem and zopiclone to treat insomnia in Alzheimer’s disease: a randomized, triple-blind, placebo-controlled trial

Neuropsychopharmacology ◽

10.1038/s41386-021-01191-3 ◽

2021 ◽

Author(s):

Luciana L. Louzada ◽

Flávio V. Machado ◽

Juliana L. Quintas ◽

Guilherme A. Ribeiro ◽

Mônica V. Silva ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Trial ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of rivastigmine in patients with Alzheimer's disease: international randomised controlled trial Commentary: Another piece of the Alzheimer's jigsaw

BMJ ◽

10.1136/bmj.318.7184.633 ◽

1999 ◽

Vol 318 (7184) ◽

pp. 633-640 ◽

Cited By ~ 545

Author(s):

M. Rosler ◽

R. Anand ◽

A. Cicin-Sain ◽

S. Gauthier ◽

Y. Agid ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomised Controlled

Download Full-text

Efficacy and safety of Cerebrolysin in moderate to moderately severe Alzheimer’s disease: results of a randomized, double-blind, controlled trial investigating three dosages of Cerebrolysin

European Journal of Neurology ◽

10.1111/j.1468-1331.2010.03092.x ◽

2010 ◽

Vol 18 (1) ◽

pp. 59-68 ◽

Cited By ~ 39

Author(s):

X. A. Alvarez ◽

R. Cacabelos ◽

C. Sampedro ◽

M. Aleixandre ◽

C. Linares ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

The efficacy and safety of the Chinese herbal medicine Di-Tan decoction for treating Alzheimer’s disease: protocol for a randomized controlled trial

Trials ◽

10.1186/s13063-015-0716-z ◽

2015 ◽

Vol 16 (1) ◽

Cited By ~ 5

Author(s):

Ka-Kit Chua ◽

Adrian Wong ◽

Pauline Wing-Lam Kwan ◽

Ju-Xian Song ◽

Lei-Lei Chen ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Randomized Controlled Trial ◽

Herbal Medicine ◽

Chinese Herbal Medicine ◽

Controlled Trial ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Chinese Herbal

Download Full-text

Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: A randomized, double-masked, placebo-controlled trial

Clinical Therapeutics ◽

10.1016/s0149-2918(00)88270-3 ◽

1999 ◽

Vol 21 (1) ◽

pp. 88-102 ◽

Cited By ~ 13

Author(s):

Michael W. Jann ◽

Pamela A. Cyrus ◽

Larry S. Eisner ◽

David L Margolin ◽

Traci Griffin ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Dose Regimen ◽

Controlled Trial ◽

Symptomatic Treatment ◽

Loading Dose ◽

Efficacy And Safety

Download Full-text

The Efficacy and Safety of Donepezil in Patients with Alzheimer's Disease: Results of a US Multicentre, Randomized, Double-Blind, Placebo-Controlled Trial

Dementia and Geriatric Cognitive Disorders ◽

10.1159/000106895 ◽

1996 ◽

Vol 7 (6) ◽

pp. 293-303 ◽

Cited By ~ 37

Author(s):

Sharon L. Rogers ◽

Lawrence T. Friedhoff

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text

A PHASE 2 MULTICENTER, RANDOMIZED, PLACEBO-CONTROLLED TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF EDONERPIC (T-817) IN PATIENTS WITH MILD TO MODERATE ALZHEIMER’S DISEASE

Alzheimer s & Dementia ◽

10.1016/j.jalz.2017.07.736 ◽

2017 ◽

Vol 13 (7) ◽

pp. P1572

Author(s):

Lon S. Schneider ◽

Ronald G. Thomas ◽

Suzanne Hendrix ◽

James B. Brewer ◽

Robert A. Rissman ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Controlled Trial ◽

Phase 2 ◽

Efficacy And Safety

Download Full-text

Efficacy and safety of AXS‐05, a novel, oral, NMDA‐receptor antagonist with multimodal activity, in agitation associated with Alzheimer’s disease: Results from ADVANCE‐1, a phase 2/3, double‐blind, active and placebo‐controlled trial

Alzheimer s & Dementia ◽

10.1002/alz.047684 ◽

2020 ◽

Vol 16 (S9) ◽

Author(s):

Cedric O'Gorman ◽

Amanda Jones ◽

Jeffrey L. Cummings ◽

Herriot Tabuteau

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nmda Receptor ◽

Receptor Antagonist ◽

Controlled Trial ◽

Nmda Receptor Antagonist ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

P4-308: Efficacy and safety of a novel acetylcholinesterase inhibitor octohydroaminoacridine in mild to moderate Alzheimer's disease: A phase ii multicenter randomized controlled trial

Alzheimer s & Dementia ◽

10.1016/j.jalz.2015.08.138 ◽

2015 ◽

Vol 11 (7S_Part_19) ◽

pp. P902-P903 ◽

Cited By ~ 1

Author(s):

Shifu Xiao ◽

Tao Wang ◽

Xia Li ◽

Zhongxin Zhao ◽

Xueyuan Liu ◽

...

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Randomized Controlled Trial ◽

Phase Ii ◽

Controlled Trial ◽

Acetylcholinesterase Inhibitor ◽

Efficacy And Safety ◽

Randomized Controlled ◽

Multicenter Randomized Controlled Trial

Download Full-text

Efficacy and safety of AXS‐05, a novel oral NMDA receptor antagonist with multimodal activity in agitation associated with Alzheimer’s disease: Results from ADVANCE‐1 — A phase 2/3, double‐blind, active and placebo‐controlled trial

Alzheimer s & Dementia ◽

10.1002/alz.048299 ◽

2020 ◽

Vol 16 (S6) ◽

Author(s):

Cedric O'Gorman ◽

Amanda Jones ◽

Jeffrey L. Cummings ◽

Herriot Tabuteau

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Nmda Receptor ◽

Receptor Antagonist ◽

Controlled Trial ◽

Nmda Receptor Antagonist ◽

Phase 2 ◽

Efficacy And Safety ◽

Double Blind

Download Full-text

P1-383 Cerebrolysin-efficacy and safety in moderate to moderately severe Alzheimer's disease: subgroup analysis of a randomized, double-blind, placebo-controlled trial

Neurobiology of Aging ◽

10.1016/s0197-4580(04)80695-x ◽

2004 ◽

Vol 25 ◽

pp. S207

Author(s):

Herbert Moessler ◽

Antòn X. Álvarez ◽

Ramón Cacabelos

Keyword(s):

Alzheimer’S Disease ◽

Alzheimer's Disease ◽

Subgroup Analysis ◽

Controlled Trial ◽

Efficacy And Safety ◽

Double Blind ◽

Double Blind Placebo

Download Full-text